Agenda Items
The Board meeting will consider the following matters:
1. Consideration and approval of the Un-Audited Financial Results (Standalone) of the Company for the first quarter ended June 30, 2026.
2. Consideration, evaluation, and potential approval of a fundraising proposal. The funds may be raised through issuance of one or more instruments including:
- Equity shares
- Warrants convertible into equity shares
The fundraising may be conducted through various methods permitted under SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, including:
- Preferential issue
- Private placements
- Rights issue
- Any other methods or combination thereof
Any fundraising would be subject to requisite approvals including shareholder and statutory approvals.
3. Transaction of other incidental and ancillary matters as may be decided by the board.